RNS
Markets
Fund Watch
Equity Bytes
Log In
Register
RNS
Markets
Fund Watch
Equity Bytes
VOX
COVID-19
Index
Vox Markets
Podcast
Vox Markets Video
VOX
COVID-19
Index
Vox Markets
Podcast
Vox Markets Video
15th January 2021
16:26
Vectura Group plc - Statement re Hikma Pharmaceuticals PLC update
12th January 2021
11:35
12th January 2021
07:02
Vectura Group plc - Trading Update
4th January 2021
13:00
Vectura Group plc - Total Voting Rights
30th December 2020
07:01
Vectura Group plc - Board Appointments
29th December 2020
09:45
Vectura Group plc - Update on GSK litigation
21st December 2020
11:18
Vectura Group plc - Holding(s) in Company
17th December 2020
17:31
Vectura Group plc - $11m milestone on US FDA Generic Advair approval
1st December 2020
15:03
Vectura Group plc - Total Voting Rights
30th November 2020
07:04
Vectura Group plc - Vectura agreement with Kinaset Therapeutics Inc.
19th November 2020
18:26
Vectura Group plc - Vectura provides update on GSK litigation
5th November 2020
14:49
Vectura Group plc - Director/PDMR Shareholding
16th October 2020
14:11
Vectura Group plc - Holding(s) in Company
15th October 2020
15:47
Vectura Group plc - Holding(s) in Company
15th October 2020
15:46
Vectura Group plc - Holding(s) in Company
1st October 2020
16:03
Vectura Group plc - Block listing six month return
1st October 2020
15:53
Vectura Group plc - Total Voting Rights
29th September 2020
06:00
Vectura Group plc - Transaction in Own Shares
28th September 2020
09:00
Vectura Group plc - Directorate Change
28th September 2020
06:01
Vectura Group plc - Transaction in Own Shares
Load more
VEC.L
Vectura Group Plc
Follow
Unfollow
Price Snapshot
Last Trades
Bid
-
-
-
Ask
High
-
OPEN
-
VOL
-
MKT CAP
-m
LOW
-
CLOSE
-
AVG VOL
-
SHARES IN ISSUE
665.39M
Details
News
Chart
Tweets
Media
Board & Advisors
More...
Company Profile
Vectura develops inhaled therapies principally for the treatment of respiratory diseases.
Classification
Market Indices
-
Watchlist